Neogen | NEOG - Cash And Equivalent


Neogen reported $145.34M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Agilent USD 1.79B 254M Sep/2025
Avanos Medical USD 70.5M 19.8M Sep/2025
Bio-Rad Laboratories USD 529.8M 134M Dec/2025
Cerus USD 15.67M 321K Sep/2025
Danaher USD 4.62B 3.09B Dec/2025
Idexx Laboratories USD 180.07M 28.1M Dec/2025
Illumina USD 1.42B 368M Dec/2025
Integra LifeSciences USD 232.19M 14.27M Sep/2025
Neogen USD 145.34M 6.46M Sep/2025
OraSure Technologies USD 216.48M 18.1M Sep/2025
Pacific Biosciences Of California USD 56.47M 1.66M Sep/2025
Quidel USD 169.8M 71.7M Dec/2025
Rockwell Medical USD 12.48M 1.09M Jun/2025
STAAR Surgical USD 176.16M 9.02M Sep/2025
Surmodics USD 36.11M 11.81M Sep/2024
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025
Utah Medical Products USD 84.27M 2.09M Sep/2025
Zoetis USD 2.08B 649M Sep/2025